Want to see TSE:CANB full AI Analyst Report?
Top Page
CanadaBis Capital
(CANB)
Select Model
Select Model
Rating:41Neutral
Price Target:
C$0.01
▼(-50.00% Downside)
Action:Reiterated
Date:04/09/26
The score is mainly weighed down by weak financial performance—especially negative and inconsistent cash flow alongside deteriorating profitability—and is reinforced by bearish technicals with the price below key moving averages and negative MACD. Valuation provides limited offset because the negative P/E reflects losses and there is no dividend support.
Positive Factors
Vertically integrated model
A vertically integrated structure gives durable control over unit costs across cultivation, processing and distribution, supporting margin resilience and operational scalability. Over months this reduces reliance on third-party supply, improving gross-margin durability and strategic pricing flexibility.
Negative Factors
Negative operating and free cash flow
Recurring negative operating and free cash flow across recent years indicates inconsistent cash conversion and elevated funding needs. Over a 2–6 month horizon this raises liquidity and refinancing risk, limiting ability to invest in growth or absorb further margin pressure without external capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Vertically integrated model
A vertically integrated structure gives durable control over unit costs across cultivation, processing and distribution, supporting margin resilience and operational scalability. Over months this reduces reliance on third-party supply, improving gross-margin durability and strategic pricing flexibility.
Read all positive factors
CanadaBis Capital (CANB) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$2.07M
Dividend YieldN/A
Average Volume (3M)63.89K
Price to Earnings (P/E)―
Beta (1Y)-1.30
Revenue Growth-12.84%
EPS Growth-681.25%
CountryCA
EmployeesN/A
SectorServices
Sector StrengthN/A
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding138,256,380
10 Day Avg. Volume172,725
30 Day Avg. Volume63,891
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.94
Price to Sales (P/S)0.37
P/FCF Ratio-1.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CanadaBis Capital Business Overview & Revenue Model
Company Description
CanadaBis Capital Inc. is a Canadian firm specializing in the production and distribution of recreational cannabis and its extracted forms. The organization's business activities are divided into three principal divisions: Cultivation and Wholesal...
How the Company Makes Money
CanadaBis Capital generates revenue primarily through the sale of cannabis products, including dried flower, pre-rolls, vape cartridges, and concentrates, to both wholesalers and end customers in the Canadian recreational cannabis market. Its vert...
CanadaBis Capital Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
52
Neutral
Cash Flow
24
Negative
| Breakdown | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 16.90M | 17.95M | 22.22M | 11.67M | 6.87M |
| Gross Profit | 6.98M | 8.82M | 11.78M | 5.57M | 2.52M |
| EBITDA | 800.05K | 2.09M | 5.68M | 1.57M | -1.81M |
| Net Income | -835.20K | 600.28K | 4.44M | 608.33K | -2.68M |
Balance Sheet | |||||
| Total Assets | 24.54M | 24.55M | 22.96M | 15.48M | 13.28M |
| Cash, Cash Equivalents and Short-Term Investments | 831.06K | 1.68M | 3.23M | 144.88K | 849.50K |
| Total Debt | 7.75M | 6.44M | 7.31M | 7.82M | 8.44M |
| Total Liabilities | 17.83M | 16.45M | 15.62M | 12.84M | 11.46M |
| Stockholders Equity | 6.62M | 8.00M | 7.25M | 2.54M | 1.73M |
Cash Flow | |||||
| Free Cash Flow | -3.37M | -594.48K | 4.57M | -292.54K | -1.96M |
| Operating Cash Flow | -3.20M | -256.31K | 5.55M | -82.77K | -1.81M |
| Investing Cash Flow | -169.65K | -328.33K | -965.82K | -209.77K | 122.77K |
| Financing Cash Flow | 2.52M | -962.02K | -1.50M | -412.09K | 2.37M |
CanadaBis Capital Technical Analysis
Neutral
0.02
Price Trends
0.02
Positive
0.02
Negative
0.03
Negative
Market Momentum
<0.01
Positive
50.16
Neutral
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CANB, the sentiment is Neutral. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 50.16 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:CANB.
CanadaBis Capital Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% | |
50 Neutral | C$4.39M | -1.66 | 50.26% | ― | -2.84% | -228.77% | |
42 Neutral | C$2.24M | -2.87 | 57.31% | ― | ― | 19.59% | |
41 Neutral | C$2.07M | -2.00 | -11.42% | ― | -12.84% | -681.25% | |
40 Underperform | C$1.95M | -0.44 | -271.33% | ― | 15.95% | -1.81% |
* Services Sector Average
TSE:CANB
CanadaBis Capital
0.02
-0.03
-62.50%
TSE:AYUR
Ayurcann Holdings Corp.
0.01
-0.02
-60.00%
TSE:BAMM
Body & Mind
0.03
0.00
0.00%
TSE:CVGR
City View Green Holdings
0.05
0.02
125.00%
TSE:CDVA
CordovaCann
0.04
-0.02
-27.27%
CanadaBis Capital Corporate Events
Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
CanadaBis Delays Q2 Financial Filings Amid Resource Constraints
Negative
Mar 30, 2026
CanadaBis Capital Inc. has announced a delay in filing its unaudited interim financial statements, management’s discussion and analysis, and related certifications for the quarter ended January 31, 2026. The documents were originally due by ...
Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
CanadaBis Shareholders Approve All Resolutions, Back Governance and Strategic Flexibility
Positive
Feb 13, 2026
CanadaBis Capital Inc., a vertically integrated Canadian cannabis producer and retailer, operates a portfolio of subsidiaries spanning cultivation, extraction and branded products, positioning the company to pursue organic growth and partnerships ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.